SCHEMBL382571

SCHEMBL382571

CC(C)(C)C(CC(=O)O)(NC(=O)c1ccc(N2CCC(Nc3nc4ccccc4[nH]3)CC2)cc1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.42
ITGAV P06756 4/20 0.42
ITGA2B P08514 1/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPK1 P28482 3/20 0.40
KCNH2 Q12809 2/20 0.38
ALDH1A1 P00352 4/20 0.38
NPC1 O15118 4/20 0.38
GAA P10253 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
SFRP1 Q8N474 1/20 0.37
HTR2B P41595 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460323 0.91 ITGB3 (0.41) ITGB3ITGAVITGA2BKCNH2MAPT
SCHEMBL383159 0.84 ITGB3 (0.44) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL382573 0.84 ITGB3 (0.43) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL382074 0.84 DRD4 (0.51) ALDH1A1NPC1GAAKDM4EMAPT
SCHEMBL383583 0.81 ITGB3 (0.61) ITGB3ITGAVITGA2BALDH1A1MAPT
SCHEMBL382991 0.80 ITGB3 (0.47) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL383467 0.79 CCR5 (0.42) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL382445 0.77 ITGB3 (0.46) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL382483 0.77 ITGB3 (0.66) ITGB3ITGAVITGA2B
SCHEMBL383120 0.77 ITGB3 (0.43) ITGB3ITGAVITGA2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed